tiprankstipranks
Trending News
More News >
Humacyte (HUMA)
NASDAQ:HUMA
US Market

Compare Humacyte (HUMA) vs. Competitors

Compare
1,590 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Humacyte
$1.19
$216.16M
-3.93
-63.16%
3 Buy
0 Hold
0 Sell
Strong Buy
Cartesian Therapeutics
$7.33
$194.31M
-1.44
-53.61%
5 Buy
1 Hold
0 Sell
Strong Buy
Allogene Therapeutics
$2.44
$594.82M
-1.58
25.77%
9 Buy
0 Hold
0 Sell
Strong Buy
Foghorn Therapeutics
$4.97
$291.74M
-4.58
12.19%
7 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.95
$519.31M
-1.77
263.60%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HUMA
Humacyte
1.12
-2.01
-64.22%
RNAC
Cartesian Therapeutics
7.33
-7.27
-49.79%
ALLO
Allogene Therapeutics
2.44
0.75
44.38%
IMAB
FHTX
Foghorn Therapeutics
4.97
0.53
11.94%
KYTX
Kyverna Therapeutics, Inc.
9.09
6.64
271.02%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts